Pancreatic cancer often has no early warning signs, which is why it is usually found at a later stage

Pancreatic cancer typically does not cause noticeable symptoms until the tumor has grown large enough to press on nearby organs or block ducts. By that point, the cancer has often spread beyond the pancreas. This is why pancreatic cancer is frequently diagnosed at stage 3 or 4, when treatment options are more limited. The symptoms that do appear—jaundice, abdominal pain, weight loss, digestive problems—are the same ones that can signal pancreatitis, gallstones, or other common conditions, which can delay diagnosis.

Detection usually begins when a person sees a doctor about symptoms or when imaging ordered for another reason happens to show a pancreatic abnormality. A few people at very high genetic risk may be screened before symptoms appear, but this is rare and happens only in specialized centers.

Key Takeaways

  • Pancreatic cancer often causes no symptoms until the tumor is large, so most cases are found at an advanced stage.
  • Jaundice (yellowing of skin and eyes), persistent abdominal or back pain, and unexplained weight loss are the most common symptoms that prompt testing.
  • Diagnosis requires imaging (CT or MRI scan) plus a tissue sample (biopsy) to confirm cancer cells are present.
  • People with a family history of pancreatic cancer or certain genetic mutations may be offered screening with endoscopic ultrasound, though this is available only at specialized centers.

Symptoms that typically lead to pancreatic cancer detection

Jaundice is one of the earliest signs people notice. It happens when a tumor blocks the bile duct, causing bile to back up into the bloodstream. The skin and whites of the eyes turn yellow, and urine becomes dark. Itching often accompanies jaundice and can be severe enough to disrupt sleep.

Abdominal or back pain is another common symptom. The pain is often dull, located in the upper abdomen or middle back, and may worsen after eating or when lying flat. Some people describe it as a gnawing sensation that comes and goes at first, then becomes constant.

Unexplained weight loss—losing 10 pounds or more without trying—occurs because the tumor interferes with digestion and nutrient absorption, or because it reduces appetite. Digestive problems like fatty, pale stools (steatorrhea) and new-onset diabetes can also appear, since the pancreas controls both fat digestion and blood sugar.

These symptoms overlap significantly with pancreatitis, which is why imaging is essential to tell them apart. A person with chronic pancreatitis who develops new or worsening symptoms should report this to their doctor, since the risk of pancreatic cancer is higher in people with a history of pancreatitis.

How imaging tests detect pancreatic tumors

A CT scan (computed tomography) is usually the first imaging test ordered. It takes detailed cross-sectional pictures of the abdomen and can show a tumor, whether it has spread to nearby organs, and whether blood vessels are involved. CT is fast, widely available, and often the test that first raises suspicion of cancer.

An MRI scan (magnetic resonance imaging) provides different detail than CT and is sometimes used alongside it or instead of it. MRI is particularly good at showing whether the tumor has invaded the bile duct or pancreatic duct. It does not use radiation, which some people prefer, but it takes longer and is not available everywhere.

Endoscopic ultrasound (EUS) is a specialized test in which a thin tube with an ultrasound probe is passed down the throat and into the small intestine, allowing the doctor to get very close to the pancreas. EUS can detect smaller tumors than CT or MRI and can obtain a tissue sample at the same time. However, it requires specialized equipment and training, so it is available only at larger medical centers.

Imaging alone cannot confirm cancer—it can show a suspicious mass, but a tissue sample is needed to know whether it is actually cancer or a benign growth.

Biopsy: how cancer is confirmed

A biopsy is a procedure in which a small sample of tissue is removed from the pancreas and examined under a microscope for cancer cells. This is the only way to definitively diagnose pancreatic cancer. There are several ways to obtain a sample.

EUS-guided biopsy is often the first choice. During the endoscopic ultrasound procedure, the doctor uses a thin needle to pass through the stomach wall and into the pancreas to collect cells. This can be done in an outpatient setting and carries lower risk than surgery.

CT-guided biopsy uses CT imaging to guide a needle into the tumor. The doctor watches the needle on the CT screen to ensure it reaches the right spot. This is also an outpatient procedure but requires the tumor to be in a location accessible by needle.

ERCP (endoscopic retrograde cholangiopancreatography) is sometimes used when the tumor is blocking a duct. A tube is passed down the throat to the small intestine, and a brush or small tool collects cells from inside the duct. This procedure also allows the doctor to place a stent to relieve blockage if needed.

In some cases, if the tumor is clearly visible on imaging and surgery is planned anyway, the surgeon may proceed directly to surgery without a biopsy first. The tissue is then examined after removal.

Blood tests and tumor markers

Blood tests alone cannot diagnose pancreatic cancer, but they provide supporting information. CA 19-9 is a protein that is often elevated in people with pancreatic cancer. However, it can also be elevated in pancreatitis, other cancers, and some benign conditions, so it is not specific enough to diagnose cancer on its own. CA 19-9 is more useful for tracking whether treatment is working or whether cancer has returned after treatment.

Other blood tests check liver function (bilirubin, alkaline phosphatase) to see whether the tumor is blocking bile ducts, and they may show signs of new-onset diabetes or poor nutrition. These tests suggest something is wrong but do not identify what it is.

Screening for pancreatic cancer in high-risk people

Most people are not screened for pancreatic cancer because no screening test has been shown to save lives in the general population, and the harms of false alarms outweigh the benefits. However, people with certain risk factors may be offered screening at specialized centers.

People with a family history of pancreatic cancer—especially if two or more relatives had it, or if a relative was diagnosed before age 50—may be candidates for screening. Screening typically involves endoscopic ultrasound performed every one to two years starting in the person's 40s or 50s, depending on family history.

People with hereditary genetic mutations that increase pancreatic cancer risk—such as BRCA2, PALB2, Lynch syndrome, or familial atypical multiple mole melanoma (FAMMM) syndrome—are also offered screening. Genetic testing is recommended for anyone with a strong family history or for people diagnosed with pancreatic cancer before age 50.

Screening in these high-risk groups sometimes finds small tumors before symptoms appear, which may allow earlier treatment. However, screening is not routine and should be discussed with a doctor who specializes in pancreatic cancer or hereditary cancer syndromes.

What happens after diagnosis

Once pancreatic cancer is confirmed by biopsy, additional imaging and tests determine the stage—how far the cancer has spread. This staging guides treatment decisions. A CT scan of the chest may be done to check for spread to the lungs, and sometimes a PET scan (which shows metabolic activity) is used to look for distant spread.

The stage, the person's overall health, and whether the tumor can be surgically removed all influence whether treatment will be surgery, chemotherapy, radiation, or a combination. People diagnosed with pancreatic cancer should be referred to a pancreatic cancer specialist or a major cancer center, since treatment is complex and outcomes are better at high-volume centers.

Frequently Asked Questions

Can pancreatitis turn into pancreatic cancer?

Chronic pancreatitis increases the risk of developing pancreatic cancer over time, but it does not directly turn into cancer. People with chronic pancreatitis should report new or worsening symptoms to their doctor, since detecting cancer early—even though it is still usually found late—offers better treatment options than waiting until symptoms are severe.

What is the difference between a pancreatic cyst and pancreatic cancer?

A cyst is a fluid-filled sac; cancer is a solid tumor of abnormal cells. Imaging can usually tell them apart, but some cysts carry a small risk of becoming cancer over time. Cysts found on imaging may need follow-up scans to watch for changes, depending on their size and appearance. Your doctor will explain whether follow-up is needed.

Why is pancreatic cancer usually found so late?

The pancreas sits deep in the abdomen, so a growing tumor does not press on the skin or cause pain until it is fairly large. Early tumors often cause no symptoms at all. By the time symptoms appear—jaundice, pain, weight loss—the cancer has usually spread to nearby organs or distant sites, making it harder to treat.

If I have a family history of pancreatic cancer, should I get screened?

If two or more close relatives had pancreatic cancer, or if a relative was diagnosed before age 50, talk to your doctor about whether screening is appropriate for you. Screening is not routine and is offered mainly at specialized cancer centers. Your doctor can refer you to a genetic counselor to discuss your risk and whether testing and screening make sense.

Does CA 19-9 blood test mean I have pancreatic cancer?

No. CA 19-9 can be elevated in pancreatic cancer, but it can also be elevated in pancreatitis, other cancers, and benign conditions. It is not used to diagnose cancer—imaging and biopsy are needed for that. CA 19-9 is most useful for tracking treatment response or watching for recurrence after cancer has been diagnosed.